Phosphatidylserine Antibodies Panel, IgG, and IgM Test Cost & Procedure

What are Phosphatidylserine Antibodies Panel, IgG, and IgM Test? Phosphatidylserine antibodies IgG and IgM are the examinations that enable the detection of Phospholipid Syndrome.

Phosphatidylserine Antibodies Panel, IgG, and IgM estimate?

Phosphatidylserine antibodies IgG and IgM are the examination that assists in the detection of Phospholipid Syndrome. Premature diagnosis of phospholipid Syndrome by the observation of Phosphatidylserine IgG antibodies which authorize the achievable precluding of thrombotic complications.

Signs and manifestations of antiphospholipid syndrome can contain:

-thrombus in your legs (DVT), signs of a DVT include ache, bulging, and redness.

-Regular  stillbirth

-Hypertension

-Sudden loss of brain

-Transient ischemic attack (TIA). Identical to a stroke, a TIA usually endures only a few minutes and causes no endless injury.

Phosphatidylserine Antibodies Panel, IgG, and IgM examination

>>Specimen Required

Patient Preparation

• Accumulate
• Serum separator pipe

Selection Preparation

Respective serum from cells ASAP or within 120 min of collection. Transfer 0.49 mL serum to an ARUP Standard Transport pipe.

Warehouse/Transport Temperature

Cooled

Inappropriate Conditions

Heat-deactivate, infected, grossly icteric, grossly decomposed, or severely lipemic specimens

Remarks

Stability

After divergence from compartments: Ambient: 48 hours; Cooled: 14 days; chilled: 30 days

New York DOH Approval Status

This test is New York DOH-approved.

Methodology

Semi-Quantitative Enzyme-Linked Immunosorbent Assay

Clinical

Reference Interval

To see all available information for this test, please view it on a tablet or desktop.

Interpretive Data

IgG and/or IgM Ab to phosphatidylserine (aPS) may be interlinked with a favorable test for anti-cardiolipin autoantibodies (aCL) and hazard for obstetric antiphospholipid syndrome. A powerful clinical connection is needed in the lack of lupus anticoagulant, IgG, and/or IgM cardiolipin, and/or beta2 glycoprotein Ab.

The solitary existence of IgM or IgG antibodies to PS may have dubious clinical importance for APS and/or SLE.

If outcomes are favorable, repeat testing with two or more instances drawn at least twelve weeks apart to indicate the endurance of antibodies.

Outcomes should not be used independently for diagnosis and must be analyzed in light of APS-specific clinical manifestations and/or other measures for phospholipid antibody examinations.